PHARMACEUTICAL M&A: DRUG PORTFOLIO ACQUISITION STRATEGIES

The pharmaceutical industry has long been a hotbed for mergers and acquisitions (M&A) activity, driven by the ongoing need for innovation, regulatory pressures, and the constant demand for expanded drug portfolios. As companies strive to stay competitive, enhance their product offerings, and streamline their research and development (R&D) p